article thumbnail

SQA Regulatory Surveillance Summary for May and June 2024

SQA

The establishment’s document control/record management system was not sufficient. The deadline to submit feedback for this plan is 25 July 2024. One Lot of ratio-ECTOSONE (TEVA-ECTOSONE) 0.05% Mild Lotion Recalled Due to an Impurity that May Pose Health Risks, 28 June 2024 Teva Canada Ltd.

FDA 52
article thumbnail

SQA Regulatory Surveillance Summary for May and June 2024

SQA

The establishments document control/record management system was not sufficient. The deadline to submit feedback for this plan is 25 July 2024. One Lot of ratio-ECTOSONE (TEVA-ECTOSONE) 0.05% Mild Lotion Recalled Due to an Impurity that May Pose Health Risks, 28 June 2024 Teva Canada Ltd.

FDA 40